Although the relapse rate in the small number of LD patients was high (62.5% relapsed at 10 years) this did not achieve significance.
← all excerpts
ChlVPP combination chemotherapy for Hodgkin's disease: long-term results.
2
—
—
The sentences
The increased risk of death in remission is significant (P<0.00001) and together with a marginally higher relapse risk (P = 0.039) results in a highly significant reduction in survival for older patients.